195 related articles for article (PubMed ID: 11318838)
1. Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus.
Ambrosch A; Dierkes J; Lobmann R; Kühne W; König W; Luley C; Lehnert H
Diabet Med; 2001 Mar; 18(3):185-92. PubMed ID: 11318838
[TBL] [Abstract][Full Text] [Related]
2. Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin.
Russo GT; Giandalia A; Romeo EL; Scarcella C; Gambadoro N; Zingale R; Forte F; Perdichizzi G; Alibrandi A; Cucinotta D
J Endocrinol Invest; 2016 Mar; 39(3):305-14. PubMed ID: 26233336
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocysteinemia is related to residual glomerular filtration and folate, but not to methylenetetrahydrofolate-reductase and methionine synthase polymorphisms, in supplemented end-stage renal disease patients undergoing hemodialysis.
Anwar W; Guéant JL; Abdelmouttaleb I; Adjalla C; Gérard P; Lemoel G; Erraess N; Moutabarrek A; Namour F
Clin Chem Lab Med; 2001 Aug; 39(8):747-52. PubMed ID: 11592445
[TBL] [Abstract][Full Text] [Related]
4. Plasma homocysteine and microvascular complications in type 1 diabetes.
Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
[TBL] [Abstract][Full Text] [Related]
5. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients.
Födinger M; Wölfl G; Fischer G; Rasoul-Rockenschaub S; Schmid R; Hörl WH; Sunder-Plassmann G
Kidney Int; 1999 Mar; 55(3):1072-80. PubMed ID: 10027946
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and the B-vitamins: a facet of nature-nurture interplay.
Herrmann W; Obeid R; Schorr H; Zarzour W; Geisel J
Clin Chem Lab Med; 2003 Apr; 41(4):547-53. PubMed ID: 12747601
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine, folate, methylene tetrahydrofolate reductase genotype and vascular morbidity in diabetic subjects.
Kaye JM; Stanton KG; McCann VJ; Vasikaran SD; Burke V; Taylor RR; van Bockxmeer FM
Clin Sci (Lond); 2002 Jun; 102(6):631-7. PubMed ID: 12049616
[TBL] [Abstract][Full Text] [Related]
8. Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese.
Moriyama Y; Okamura T; Kajinami K; Iso H; Inazu A; Kawashiri M; Mizuno M; Takeda Y; Sakamoto Y; Kimura H; Suzuki H; Mabuchi H
Atherosclerosis; 2002 Oct; 164(2):321-8. PubMed ID: 12204804
[TBL] [Abstract][Full Text] [Related]
9. Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease.
de Jong SC; Stehouwer CD; van den Berg M; Kostense PJ; Alders D; Jakobs C; Pals G; Rauwerda JA
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1316-24. PubMed ID: 10323785
[TBL] [Abstract][Full Text] [Related]
10. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
Postiglione A; Milan G; Ruocco A; Gallotta G; Guiotto G; Di Minno G
Gerontology; 2001; 47(6):324-9. PubMed ID: 11721146
[TBL] [Abstract][Full Text] [Related]
11. Plasma homocysteine and its determinants in diabetic retinopathy.
Vaccaro O; Perna AF; Mancini FP; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
Diabetes Care; 2000 Jul; 23(7):1026-7. PubMed ID: 10895864
[No Abstract] [Full Text] [Related]
12. Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study.
Bjelland I; Tell GS; Vollset SE; Refsum H; Ueland PM
Arch Gen Psychiatry; 2003 Jun; 60(6):618-26. PubMed ID: 12796225
[TBL] [Abstract][Full Text] [Related]
13. Circulating homocysteine levels in patients with type 2 diabetes mellitus.
Ndrepepa G; Kastrati A; Braun S; Koch W; Kölling K; Mehilli J; Schömig A
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):66-73. PubMed ID: 17027242
[TBL] [Abstract][Full Text] [Related]
14. Methyltetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia as a novel risk factor for diabetic nephropathy.
Ukinc K; Ersoz HO; Karahan C; Erem C; Eminagaoglu S; Hacihasanoglu AB; Yilmaz M; Kocak M
Endocrine; 2009 Oct; 36(2):255-61. PubMed ID: 19598005
[TBL] [Abstract][Full Text] [Related]
15. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus.
Wollesen F; Brattström L; Refsum H; Ueland PM; Berglund L; Berne C
Kidney Int; 1999 Mar; 55(3):1028-35. PubMed ID: 10027940
[TBL] [Abstract][Full Text] [Related]
16. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
Ventura P; Panini R; Emiliani S; Salvioli G
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):44-51. PubMed ID: 14758571
[TBL] [Abstract][Full Text] [Related]
17. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.
Bostom AG; Shemin D; Lapane KL; Nadeau MR; Sutherland P; Chan J; Rozen R; Yoburn D; Jacques PF; Selhub J; Rosenberg IH
Atherosclerosis; 1996 Jun; 123(1-2):193-202. PubMed ID: 8782850
[TBL] [Abstract][Full Text] [Related]
18. Anti-epileptic drug treatment in children: hyperhomocysteinaemia, B-vitamins and the 677C-->T mutation of the methylenetetrahydrofolate reductase gene.
Vilaseca MA; Monrós E; Artuch R; Colomé C; Farré C; Valls C; Cardo E; Pineda M
Eur J Paediatr Neurol; 2000; 4(6):269-77. PubMed ID: 11277368
[TBL] [Abstract][Full Text] [Related]
19. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
